 SOUTH SAN FRANCISCO, Calif.--BUSINESS WIRE--Twist Bioscience Corporation NASDAQ: TWST, a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today reported financial results and business highlights for the third quarter of fiscal 2021 ended June 30, 2021. It is an exciting time to be at the forefront of synthetic biology, said Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience. The opportunity continues to exp 